Richard A. Heyman, a director at $ORIC, sold 3,200 shares of the company on 01-16-2026 for an estimated $38,414. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.5% of their shares of this class of stock. Following this trade, they now own 213,072 shares of this class of $ORIC stock.
$ORIC Insider Trading Activity
$ORIC insiders have traded $ORIC stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $ORIC stock by insiders over the last 6 months:
- JACOB CHACKO (PRESIDENT AND CEO) has made 0 purchases and 5 sales selling 283,374 shares for an estimated $3,167,380.
- DOMINIC PISCITELLI (Chief Financial Officer) has made 0 purchases and 2 sales selling 21,720 shares for an estimated $256,846.
- PRATIK S MULTANI (Chief Medical Officer) sold 10,720 shares for an estimated $97,128
- RICHARD A. HEYMAN has made 0 purchases and 2 sales selling 6,700 shares for an estimated $80,430.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ORIC Hedge Fund Activity
We have seen 89 institutional investors add shares of $ORIC stock to their portfolio, and 57 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ECOR1 CAPITAL, LLC added 5,110,048 shares (+315.8%) to their portfolio in Q3 2025, for an estimated $61,320,576
- ORBIMED ADVISORS LLC added 2,742,475 shares (+305.0%) to their portfolio in Q3 2025, for an estimated $32,909,700
- VANGUARD GROUP INC added 1,525,445 shares (+48.8%) to their portfolio in Q3 2025, for an estimated $18,305,340
- ROYCE & ASSOCIATES LP added 1,223,709 shares (+521.2%) to their portfolio in Q3 2025, for an estimated $14,684,508
- BLACKROCK, INC. added 1,198,635 shares (+29.4%) to their portfolio in Q3 2025, for an estimated $14,383,620
- FRAZIER LIFE SCIENCES MANAGEMENT, L.P. removed 1,065,334 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $12,784,008
- STATE STREET CORP added 771,823 shares (+47.3%) to their portfolio in Q3 2025, for an estimated $9,261,876
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ORIC Analyst Ratings
Wall Street analysts have issued reports on $ORIC in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Evercore ISI Group issued a "Outperform" rating on 11/20/2025
- JP Morgan issued a "Overweight" rating on 11/18/2025
- Citigroup issued a "Buy" rating on 11/17/2025
- HC Wainwright & Co. issued a "Buy" rating on 11/14/2025
- Oppenheimer issued a "Outperform" rating on 11/14/2025
- Wells Fargo issued a "Overweight" rating on 11/14/2025
To track analyst ratings and price targets for $ORIC, check out Quiver Quantitative's $ORIC forecast page.
$ORIC Price Targets
Multiple analysts have issued price targets for $ORIC recently. We have seen 10 analysts offer price targets for $ORIC in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- David Nierengarten from Wedbush set a target price of $20.0 on 01/13/2026
- Kelsey Goodwin from Piper Sandler set a target price of $22.0 on 01/07/2026
- Derek Archila from Wells Fargo set a target price of $25.0 on 12/08/2025
- Cory Kasimov from Evercore ISI Group set a target price of $25.0 on 11/20/2025
- Anupam Rama from JP Morgan set a target price of $20.0 on 11/18/2025
- Yigal Nochomovitz from Citigroup set a target price of $16.0 on 11/17/2025
- Robert Burns from HC Wainwright & Co. set a target price of $23.0 on 11/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
